Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

Neurogastroenterology and Motility

Volumn 14, Issue 2, 2002, Pages 123-131

  Vella, A ^a   Lee, J S ^a   Camilleri, M ^a   Szarka, L A ^a   Burton, D D ^a   Zinsmeister, A R ^a   Rizza, R A ^a   Klein, P D ^b  

^a MAYO CLINIC   (United States)

^b Meretek Diagnostics Inc   (United States)

Author keywords

Glucose; Pancreatic polypeptide

Indexed keywords

AMYLIN; CARBON 13; PANCREAS POLYPEPTIDE; PRAMLINTIDE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; STOMACH MOTILITY;

AGED; AMYLOID; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTRIC EMPTYING; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0036248752     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2002.00311.x     Document Type: Article

References (40)

1. Amylin regulation of carbohydrate metabolism
2. Amylin concentrations and glucose control
3. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes
4. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
5. Beta-cell apoptosis: Stimuli and signaling
6. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats
7. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM
8. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM
9. Dose-response for glucagon static effect of amylin in rats
10. Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus
11. Structure and biology of amylin
12. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue
13. Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM. Effects on plasma glucose profiles and serum fructosamine concentrations
14. Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type II diabetes using insulin
15. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injection of amylin
16. The molecular pharmacology of CGRP and related peptide receptor subtypes
17. Abnormalities in G protein-coupled signal transduction pathways in human disease
18. The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study
19. A patient questionnaire to identify bowel disease
20. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics
21. A valid, accurate, office-based, nonradioactive test for gastric emptying of solids
22. 2 measurements
23. 2 breath tests: Methodology and fundamental considerations
24. Predicting basal metabolic rate, new standards and review of previous work
25. 2 production rates in children
26. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction
27. Neurohormonal factors in functional dyspepsia: Insights on pathophysiological mechanisms
28. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1 (7-36) amide in non-insulin dependent diabetes mellitus
29. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques
30. Neural regulation of pancreatic polypeptide release
31. Time-dependent effects of vagotomy on pancreatic polypeptide release
32. Effect of proximal gastric, complete gastric, and truncal vagotomy on canine gastric electric activity, motility, and empyting
33. The pancreatic polypeptide family
34. Pramlintide, an amylin analog, selectively delays gastric emptying: Potential role of vagal inhibition
35. Can plasma pancreatic polypeptide be used to detect diseases of the exocrine pancreas?
36. Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake
37. High affinity amylin binding sites in rat brain
38. In vitro autoradiographic localization of amylin binding sites in rat brain
39. Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas
40. Natural history of diabetic gastroparesis